Lecture: Immunology in Cardiometabolic Disease
Emerging research has highlighted the critical involvement of the immune system, especially chronic low-grade inflammation, in the development and progression of cardiovascular disease (CVD). Join us for a Thursday afternoon lecture where we are exploring the potential of using immunomodulation in the prevention and treatment of CVD.
Read more
Intro
The understanding of cardiovascular disease (CVD) has traditionally focused on factors such as high blood pressure and elevated cholesterol levels. However, emerging research has highlighted the critical involvement of the immune system, especially chronic low-grade inflammation, in the development and progression of CVD. Numerous factors can contribute to low-grade inflammation including diet, obesity, and diabetes. Chronic inflammation is a risk factor for CVD where it especially promotes the progression of atherosclerosis. Individuals at risk of CVD are often treated with lipid-lowering drugs, which reduces the risk of cardiovascular events with by approx. 30%. Evidence suggests that the residual risk is linked to inflammation, calling for the need to develop effective and safe anti-inflammatory strategies for the prevention and treatment of CVD.
Daniel F. J. Ketelhuth, Professor, University of Southern Denmark
Michael J. Davies, Professor, University of Copenhagen
Susanne Brix Pedersen, Professor, Technical University of Denmark
Important Dates
Facts
Programme
